Imaging biomarker predicts response to rapid antidepressant

Signals dysfunction in brain system targeted by scopolamine – NIH study

A telltale boost of activity at the back of the brain while processing emotional information predicted whether depressed patients would respond to an experimental rapid-acting antidepressant, a National Institutes of Health study has found.

Read more View All News

This page was last updated on Friday, January 21, 2022